Curcumin Sensitizes Lung Cancer Cells to Cisplatin-Induced Apoptosis Through Superoxide Anion-Mediated Bcl-2 Degradation

被引:73
作者
Chanvorachote, Pithi [1 ]
Pongrakhananon, Varisa [2 ]
Wannachaiyasit, Sumalee [3 ]
Luanpitpong, Sudjit [2 ]
Rojanasakul, Yon [4 ]
Nimmannit, Ubonthip [2 ]
机构
[1] Chulalongkorn Univ, Dept Physiol, Fac Pharmaceut Sci, Bangkok 10330, Thailand
[2] Chulalongkorn Univ, Pharmaceut Technol Int Program, Fac Pharmaceut Sci, Bangkok 10330, Thailand
[3] Silpakorn Univ, Fac Pharm, Dept Biopharm, Nakhon Pathom, Thailand
[4] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA
关键词
Curcumin; Cisplatin; Apoptosis; Lung cancer; Bcl-2; degradation; OVARIAN-CANCER; CARCINOMA-CELLS; KAPPA-B; SIGNALING PATHWAY; BLADDER-CANCER; EXPRESSION; ACTIVATION; RESISTANCE; INHIBITION; PROTEIN;
D O I
10.1080/07357900802653472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to investigate the sensitizing effect of curcumin on cisplatin-induced apoptosis in non-small cell lung cancer (NSCLC) H460 cells. Curcumin was shown to induce superoxide anion generation, down-regulate anti-apoptotic Bcl-2 protein, and subsequently sensitize cells to cisplatin-induced apoptosis. Co-treatment of the cells with curcumin and cisplatin resulted in increased apoptosis and reversal of Bcl-2-mediated cisplatin resistance. The mechanism by which curcumin down-regulates Bcl-2 and sensitizes cells to cisplatin-induced apoptosis involves proteasomal degradation of Bcl-2. These findings indicate a novel pathway for curcumin regulation of Bcl-2, which could benefit the development of a cisplatin sensitizing agent.
引用
收藏
页码:624 / 635
页数:12
相关论文
共 50 条
[1]   Life-or-death decisions by the Bcl-2 protein family [J].
Adams, JM ;
Cory, S .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) :61-66
[2]  
Aggarwal BB, 2003, ANTICANCER RES, V23, P363
[3]   Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation [J].
Aggarwal, S ;
Ichikawa, H ;
Takada, Y ;
Sandur, SK ;
Shishodia, S ;
Aggarwal, BB .
MOLECULAR PHARMACOLOGY, 2006, 69 (01) :195-206
[4]   ENHANCED POTENTIATION OF CISPLATIN CYTO-TOXICITY IN HUMAN OVARIAN-CARCINOMA CELLS BY PROLONGED GLUTATHIONE DEPLETION [J].
ANDREWS, PA ;
SCHIEFER, MA ;
MURPHY, MP ;
HOWELL, SB .
CHEMICO-BIOLOGICAL INTERACTIONS, 1988, 65 (01) :51-58
[5]   Relationship between intracellular ROS production and membrane mobility in curcumin- and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells [J].
Atsumi, T ;
Fujisawa, S ;
Tonosaki, K .
ORAL DISEASES, 2005, 11 (04) :236-242
[6]  
BENEZRA JM, 1994, AM J PATHOL, V145, P1036
[7]   Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates [J].
Bhaumik, S ;
Anjum, R ;
Rangaraj, N ;
Pardhasaradhi, BVV ;
Khar, A .
FEBS LETTERS, 1999, 456 (02) :311-314
[8]   Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway [J].
Breitschopf, K ;
Haendeler, J ;
Malchow, P ;
Zeiher, AM ;
Dimmeler, S .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1886-1896
[9]   Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination [J].
Chanvorachote, Pithi ;
Nimmannit, Ubonthip ;
Stehlik, Christian ;
Wang, Liying ;
Jiang, Bing-Hua ;
Ongpipatanakul, Boonsri ;
Rojanasakul, Yon .
CANCER RESEARCH, 2006, 66 (12) :6353-6360
[10]  
CIEHANOVER A, 1998, P NATL ACAD SCI USA, V95, P2727